Keystone Financial Group (Georgia)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Keystone Financial Group (Georgia)'s ABBV Position: Q2 2026 in Review
Keystone Financial Group (Georgia) reduced its AbbVie (ABBV) stake by 8.3% in Q2 2026, selling an estimated $20.2K and leaving 1,045 shares worth $263K. The position accounts for 0.14% of the portfolio, ranked #49.
Keystone Financial Group (Georgia) first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Keystone Financial Group (Georgia) held 1,045 shares of AbbVie worth $263K as of Q2 2026.
- Keystone Financial Group (Georgia) sold 94 AbbVie shares in Q2 2026, an estimated $20.2K.
- AbbVie made up 0.14% of Keystone Financial Group (Georgia)'s portfolio in Q2 2026, its #49 holding.
- Keystone Financial Group (Georgia) first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Keystone Financial Group (Georgia)'s 13F filing for Q2 2026, filed 21 Jul 2026.